1. Cytomegalovirus in hematopoietic stem cell transplant recipients;Boeckh,2003
2. Clinical aspects of CMV infection after stem cell transplantation;Hebart,2004
3. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants;Schmidt,1991
4. Preemptive therapy in immunocompromised hosts;Rubin,1991
5. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation;Einsele,1995